CFDE Data Portal | Search RPL7AP47

	Label	Description
	RPL7AP47 Gene (Entity type)	ENSG00000234982 - ribosomal protein L7a pseudogene 47
	GSE203329 HCC knockout 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 4 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Heart 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Liver 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Ovary 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx SmallIntestine 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE196505 GSE196507 KDM2B overexpression E-CS 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE144279 GSE144280 MBD5 knockdown neuron 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 8 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

RPL7AP47

ENSG00000234982 - ribosomal protein L7a pseudogene 47

GSE203329 HCC knockout 2 v 1 human dn

A Gene Set from LINCS

GSE176008 pyridoxine 4 v 2 human dn

A Gene Set from LINCS

GTEx Heart 20-29 vs 30-39 Down

A Gene Set from GTEx

GTEx Liver 20-29 vs 30-39 Up

A Gene Set from GTEx

GTEx Ovary 20-29 vs 30-39 Up

A Gene Set from GTEx

GTEx SmallIntestine 20-29 vs 60-69 Up

A Gene Set from GTEx

GSE196505 GSE196507 KDM2B overexpression E-CS 3 v 2 human dn

A Gene Set from LINCS

GSE144279 GSE144280 MBD5 knockdown neuron 2 v 3 human dn

A Gene Set from LINCS

GSE176008 pyridoxine 8 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.